is the only journal exclusively devoted to the etiology, cellular and molecular mechanisms, and therapeutic approaches to the treatment of shock in a comprehensive and coherent manner, while still maintaining a clear focus on the pathobiology of shock. The journal includes studies of novel therapeutic approaches, such as immunomodulation, gene therapy, nutrition, and others. SHOCK®
is dedicated to meeting the present and future information needs of investigators involved in sophisticated basic and clinical studies of shock, trauma, sepsis, endotoxemia, ischemia/reperfusion, inflammation, and other related pathophysiologic states.
An individual subscription includes 6 print issues and full-text online access to all current and back issues.
Visit the journal online at shockjournal.com